Helio Genomics Presents Four Studies at the San Antonio Liver Cancer Symposium
Posters explore whether HelioLiver™ Dx can flag hepatocellular carcinoma when ultrasound is negative, imaging is indeterminate, or a tumor is not yet visible SAN ANTONIO, Oct. 9, 2026 /PRNewswire/ -- Helio Genomics today announced four poster presentations at the San Antonio Liver Cancer...
Extrait seulement — cet éditeur protège son texte. Lisez le communiqué complet à la source.
Résiliable à tout moment · 99 $ CA/mois


